ATRA-BA Hybrid, CAS [[1037543-26-2]]

Produktübersicht

• Artikelname: ATRA-BA Hybrid, CAS [[1037543-26-2]]
• Artikelnummer: TGM-T35629
• Hersteller Artikelnummer: T35629
• Alternativnummer: TGM-T35629-1MG,TGM-T35629-5MG,TGM-T35629-10MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

ATRA-BA hybrid is a mutual prodrug form of all-transretinoic acid and butyric acid .1ATRA-BA hybrid is cleaved to release ATRA and BA in isolated mouse plasma. It inhibits the growth of MDA-MB-231 breast and PC3 prostate cancer cells with GI50values of 0.01 and 1.02 µM, respectively. ATRA-BA (20 µM) has 15-fold greater antiproliferative activity in PC3 cells compared to an equimolar concentration of ATRA and BA.

Produkteigenschaften

• Molekulargewicht: 476.65
• CAS Nummer: [1037543-26-2]
• Formel: C31H40O4
• Target-Kategorie: Others

Bilder

T35629